Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2023. For the year, the company's net sales to be ¥6,400 million, operating profit to be ¥(800)million, net income to be ¥(950) million or Basic earnings per share to be ¥(20.42).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
382 JPY | -2.55% | -4.74% | +26.07% |
1st Jan change | Capi. | |
---|---|---|
+26.07% | 126M | |
+20.48% | 44.39B | |
+20.08% | 22.46B | |
+18.74% | 15.04B | |
+19.27% | 13.98B | |
+55.29% | 13.15B | |
-10.55% | 6.89B | |
-0.05% | 6.79B | |
+14.03% | 5.71B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023